This announcement is a separate document:
海辰药业：关于公司富马酸丙酚替诺福韦片获得药品注册批件的公告
Nanjing Hicin Pharmaceutical: Announcement on the pharmaceutical registration approval of propofol and tenofovir disoproxil fumarate tablets of the company.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.